On our screens:Stocks with no debt
What is the market doing?
What the tape says about BIO
Bio-Rad Laboratories, Inc. is +34% over the past year while the S&P 500 is +20%: 13 points ahead of the market.
+34%
1-year return · S&P 500 +20%
- vs 200-day average
- +26%
vs 200-day average · a clear uptrend
- RSI (14)
- 69
RSI (14) · neutral
- Below its 52-week high
- 2.6%
Below its 52-week high
Details›
- Last close2026-09-08
- $380.17
- 1 monthS&P 500 −0.30%
- +11%
- 1 yearS&P 500 +20%
- +34%
- 5 yearsS&P 500 +85%
- −49%
- vs 50-day average$332.24
- +14%
- 52-week high
- $390.31
- 52-week low
- $241.71
- Annualised volatility
- 41%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$136K
| Year | Return |
|---|---|
| 2026 (year to date) | +25% |
| 2025 | −7.8% |
| 2024 | +1.7% |
| 2023 | −23% |
| 2022 | −44% |
| 2021 | +30% |
| 2020 | +58% |
| 2019 | +59% |
| 2018 | −2.7% |
| 2017 | +31% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 5 of 10 | +1.3% |
| Feb | 10 | 7 of 10 | −0.89% |
| Mar | 10 | 5 of 10 | −0.65% |
| Apr | 10 | 6 of 10 | +0.90% |
| May | 10 | 6 of 10 | +1.7% |
| Jun | 10 | 6 of 10 | +0.01% |
| Jul | 11 | 11 of 11 | +9.0% |
| Aug | 11 | 6 of 11 | +3.5% |
| Sep | 11 | 3 of 11 | −2.9% |
| Oct | 10 | 4 of 10 | −1.5% |
| Nov | 10 | 7 of 10 | +5.7% |
| Dec | 10 | 6 of 10 | −1.7% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Medical Devices
Ranks #21 of 29 by Smart Score